Loading
RX
RxBids Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BROWN STEPHEN RUSSELL, was filed 16 May 2011.
RxBids: what insiders have been doing
Every trade that managers of RxBids disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for RxBids. The previous disclosure was published on 16 May 2011.
Over the whole record (from 2011), the tally stands at 2 purchases and 2 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
2 ops. · all time
Sell Volume
€63,458
2 ops. · all time
Last declaration on 16 May 2011
Declarations4 total
25,000 sharesSeries A Preferred StockSEC:0001144204-11-030327:0
Canonical exit: 4 Aug 2011 (T+90)
25,000 sharesSeries A Preferred StockSEC:0001144204-11-029218:0
Canonical exit: 4 Aug 2011 (T+90)
2,000,000 shares@ US$0.03Common StockSEC:0001010412-11-000017:0
173,333 shares@ US$0.1549Common StockSEC:0001010412-11-000013:0
4 of 4 declarations
About RxBids
RxBids is a company listed on the XNAS market, specializing in auction management solutions for the pharmaceutical sector. It offers tools to optimize the buying and selling processes of medications.
